Functional analysis of SRY variants in individuals with 46,XY differences of sex development

Autor(es)

van den Bergen, Jocelyn ; Robevska, Gorjana ; Ferreira, Lucas G. A. ; Ferreira, Karen R. ; Kizys, Marina M. L. ; da Silva, Magnus R. Dias ; Bruggenwirth, Hennie T. ; van Bever, Yolande ; Sinclair, Andrew H. ; Ayers, Katie L.

• Tipo de documento: Artigo Científico
• Fonte: Molecular and Cellular Endocrinology; v. 598, p. 9-pg., 2025-01-11.

Resumo

In mammals, male sexual development is initiated by the expression of the Sex-determining-Region-Y (SRY) gene. SRY contains a highly conserved high mobility group (HMG) box essential for DNA binding and activity. Variants in SRY cause Differences of Sex Development (DSD), accounting for 10-15% of 46, XY gonadal dysgenesis cases. Here, we present the functional analysis of five SRY coding variants identified in patients with 46, XY DSD. Four variants (p.Asp58Glu, p.Arg75Lys, p.Met85Thr, and p.Arg86Ter) are located within the HMG box and one variant (p.Tyr198Cysfs*18) located in the C-terminal domain. We functionally characterise the impact of these variants in vitro, investigating SRY localisation and transactivational activity using SOX9 regulatory elements that are responsive to SRY. We find that three variants (p.Met85Thr, p.Arg86Ter, and p.Tyr198Cysfs*18) have reduced or abolished transactivational activity suggesting these are pathogenic, with the p.Arg86Ter variant undetectable in our assays and the p.Met85Thr variant exhibiting reduced nuclear localisation. The pathogenic mechanisms underlying reduced activity of the novel elongated p.Tyr198Cysfs*18 variant is however unclear, although this variant also affected localisation. In contrast, two additional variants (p.Asp58Glu and p.Arg75Lys) had no discernible effects on nuclear localisation or transactivational activity despite in silico analysis predicting impaired DNA binding. Taken together, our data establish the likely pathogenicity of these SRY variants and improve diagnostic certainty for the patients in which they were identified. (AU)

• Processo FAPESP: 21/00684-3 - Sequenciamento de nova geração e avaliação funcional de variantes genéticas em indivíduos com DDS 46,XX testicular/ ovotesticular SRY-negativo
• Beneficiário: Magnus Régios Dias da Silva
• Modalidade de apoio: Auxílio à Pesquisa - Regular
• Processo FAPESP: 22/10804-9 - Neoplasia Endócrina Múltipla Tipo 2 e Carcinoma Medular da Tiroide: novas questões da biologia do desenvolvimento, genética, imunologia, epidemiologia, mecanismo de doença e manejo clínico
• Beneficiário: Marina Malta Letro Kizys Polisel
• Modalidade de apoio: Bolsas no Brasil - Pós-Doutorado